Objectives: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by strategic white matter (WM) hyperintensities on MRI. Pathological features include WM degeneration, arteriolosclerosis, lacunar infarcts, and the deposition of granular osmiophilic material. Based on the hypothesis that the gliovascular unit is compromised, we assessed the nature of astrocyte damage in the deep WM of CADASIL subjects. Methods: We evaluated post-mortem brains from CADASIL, cerebral small vessel disease, similar age cognitively normal and older control subjects. Standard immunohistochemical, immunofluorescent, and unbiased stereological methods were used to evaluate the distribution of astrocytes, microvessels, and autophagy markers in five different brain regions. Results: Compared to the controls, the deep WM of CADASIL subjects overall showed increased numbers of glial fibrillary acidic protein (GFAP)-positive clasmatodendritic astrocytes (P=0.037) and a decrease in the percentage of normal appearing astrocytes (P=0.025). In accord with confluent WM hyperintensities, the anterior temporal pole contained abundant clasmatodendritic astrocytes with displaced aquaporin 4 immunoreactivity. Remarkably, we also found strong evidence for the immunolocalization of autophagy markers including microtubuleassociated protein 1, light chain 3 (LC3), and sequestosome 1/p62 and Caspase-3 in GFAP-positive clasmatodendritic cells, particularly within perivascular regions of the deep WM. LC3 was co-localized in more than 90% of the GFAP-positive clasmatodendrocytes. Conclusions: Our novel findings show astrocytes undergo autophagylike cell death in CADASIL, with the anterior temporal pole being highly vulnerable. We propose astrocytes transform from normal appearing type A to hypertrophic type B and eventually to clasmatodendritic type C cells. These observations also suggest the gliovascular unit of the deep WM is severely impaired in CADASIL.
INTRODUCTION
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common widely occurring hereditary stroke disorder leading to cognitive impairment and dementia (4, 38) . It is caused by over 250 distinct mutations in the NOTCH3 gene. In addition to the presence of severe arteriopathy, lacunar infarcts, and deep white matter (WM) changes, CADASIL is characterized by the presence of aggregated NOTCH3 extracellular domain fragments within in granular osmiophilic material (GOM) (38, 39) . Hypomorphic NOTCH3 function, causing a partial loss of NOTCH3 protein function in vascular smooth muscle cells is also characteristic of CADASIL (2) . However, WM hyperintensities identified on magnetic resonance imaging (MRI) in the anterior temporal pole and external capsule are key radiological signatures of CADASIL. We previously demonstrated that WM hyperintensities in the anterior temporal pole largely align with perivascular spaces and highly rarefied tissue (40) . The degeneration and axonal disconnectivity in the WM (9) is associated with abnormalities in oligodendrocytes and accumulation of degraded myelin basic protein. Oligodendrocytes together with astrocytes and microglia also form the gliovascular unit. We recently showed that astrocytes transform to clasmatodendrocytes in the deep WM of elderly post-mortem stroke survivors, who develop dementia (6) . This implicates disruption of the gliovascular unit and loss of integrity of the blood-brain barrier (BBB) in the WM. The cellular mechanisms involved in astrocytic transformation and whether any protective mechanisms are implicated are unknown (3) . We therefore reasoned that CADASIL in which there is severe WM degeneration will be pivotal to examine cellular mechanisms involved astrocyte pathology.
Major mechanisms of cell death after ischemia are apoptosis and necrosis, and both have been implicated in delayed neuronal cell death after hypoxic-ischemic injury (14) . Macroautophagy, a degradation pathway for organelles and long-lived proteins too large to be degraded by the ubiquitin-proteasome system, is also triggered in cells after hypoxic and excitotoxic injury, and excessive or imbalanced induction can contribute to cell death (7, 20) . Although there have been numerous reports on the role of autophagy in neurodegenerative diseases, there is lack of autophagy studies in relation to cerebrovascular disorders including in CADASIL or post-stroke dementia. Growing evidence suggests autophagy is enhanced following cerebral ischemia, and is stimulated in response to in vivo or in vitro instigated energy deficits, hypoxia, endoplasmic reticulum stress, and oxidative stress (20, 28, 37) . The two most commonly studied proteins involved in autophagy are LC3 (microtubule-associated protein 1, light chain 3) and Beclin-1. During the initiation of autophagy, LC3-I becomes anchored to the autophagic vacuole membrane to form LC3-II, a specific marker for autophagosomes. Beclin-1 is involved in the recruitment of the membranes which form the autophagosomes, and also interacts with anti-apoptotic protein B-cell lymphoma 2 as an upstream gatekeeper of apoptosis (27) . Another protein which has been suggested to have a pathogenic role in autophagy dysfunction is sequestosome 1 (SQSTM1), or more commonly known as p62, a regulatory protein involved in protein homeostasis and DNA repair (17) . p62 binds directly to LC3 and can target protein aggregates and organelles for autophagic degradation, and has a role in regulating the degradation of ubiquitinated tau (26) . In an effort to evaluate the integrity of the gliovascular unit and mechanisms of astrocytic cell death, we aimed to study the distribution and quantify the expression of GFAP immunoreactive cells and protein markers of autophagy in different regions of the WM in CADASIL against similar age controls.
METHODS

Subjects and tissues
Demographic details and diagnoses of the subjects are shown in Table 1 . The mean age of the CADASIL and young control subjects were not different. Available case notes and radiological reports indicated CADASIL subjects showed extensive WM changes consistent with small vessel disease and met the minimum criteria for cognitive impairment (1). 
Immunohistochemistry and immunofluorescence (IF) labeling
Formalin-fixed paraffin-embedded post-mortem WM brain tissue from five different regions including the pre-frontal lobe (PF), temporal pole (TP), temporal lobe (TL), parietal lateral lobe (PL), and occipital inferior lobe (OL) were examined. These extended along the rostro-caudal axis of the cerebrum, per atlas of Perry and Oakley (24) . The blocks were cut serially at 10-μm thickness for routine tinctorial staining and immunohistochemistry as described previously (40) . Macroscopic and microscopic pathology was assessed using standardized protocols as described (10, 19) . Haemotoxylin and eosin (H&E), luxol fast blue (LFB) and cresyl fast violet (CFV) were used as standard stains for describing neuropathological changes and for detection of infarcts, presence of WM rarefaction, and extent of arteriopathy. Cerebrovascular lesions including SVD pathology were assessed using a grading system as described previously (10) . Vascular sclerotic index (SI) was assessed as described previously (40) . Ten-micrometer-thick paraffin wax embedded coronal sections were immunostained with various primary mouse monoclonal and rabbit or goat polyclonal antibodies including, aldehyde dehydrogenase 1 family, member L1 (ALDH1L1; 1:100 in 0.1% Trion X-100-PBS for IF, clone 7G8, mouse, 14-9595, eBioscience), aquaporin 4 (AQP4; 1:50, rabbit, 16473-1-AP, Proteintech), Beclin-1 (1:100, mouse, AM1818a, Abgent), Caspase-3 (Cleaved Caspase-3, 1:100, Asp175, rabbit; product #9661, Cell Signaling Technology), Collagen IV (COL4, 1:1000, mouse, C1926, Sigma); Delta Like-1 (DLL1; 1:1000, rabbit, Ab# 76655 Abcam), fibrinogen (1:2000, rabbit, A0080, Dako), GFAP (1:1000, rabbit, Z0334, Dako), GFAP mouse antibody (1:50, clone 6F2, monoclonal M0761, Dako), glucose transporter-1 (GLUT-1, 1:200, rabbit, #21041, Thermo Scientific), Intercellular adhesion molecule-1 (ICAM-1, CD54, 1:300, mouse, F1743, Dako), LC3 (autophagic vacuoles; 1:100, rabbit, AP1801a, Abgent), p62 (1:300, mouse, #610832, BD Biosciences). Tissue sections first underwent antigen retrieval by heating in the microwave with citrate buffer for 12 min before being quenched with TBS and 3% hydrogen peroxide. Sections were then blocked with serum derived from the species in which the secondary antibody was generated, before being immunostained with the primary antibody overnight at 4°C. Specificities of the GFAP, LC3, p62, and Caspase-3 antibodies were either verified per manufacturer's datasheet or immunostaining of cortical tissue or sections without primary antibody as described previously (8, 9) .
Quantification was performed following the general pattern we established previously for either parenchymal or cellular protein immunoreactivity (12, 18) . Briefly for GFAPpositive cells, at least 20 images were acquired randomly from areas of the deep WM in coronal sections (Figure 2 ), using a Leitz DIALUX 20 brightfield microscope coupled to a lumenera infinity digital camera at 10× magnification. Using ImageJ, the total GFAP+ cells and cells showing features of clasmatodendrosis (swollen cell body and beaded processes) were counted from frontal, temporal, parietal, and occipital deep WM in each case, with the percentage of GFAP+ clasmatodendrotic and normal astroglia per total GFAP+ cells were calculated. To verify that only astrocytic cells were targeted, we determined that GFAP cell counts per 0.5 mm 2 correlated positively with GFAP staining per unit area (ρ = 0.754, P < 0.001). We also showed there was a positive correlation between the frontal and temporal total GFAP immunoreactivities (ρ = 0.500, P = 0.003).
For immunofluorescence labeling, the primary antibodies were removed and sections were washed with PBS prior to incubation at room temperature for 1 hour with goat anti-mouse secondary antibody, Dylight 650 conjugated (1:200, 84545, Thermo Scientific) and goat anti-rabbit secondary antibody, Texas Red conjugated (1:200, T2767, Life Technologies). Sections were counterstained and mounted with DAPI incorporated mounting medium (Dako). A Leica TCS SP2 UV AOBS MP (upright confocal microscope) and a Life Technologies EVOS FL (LED) fluorescence microscope were used for image capture.
Statistical analysis
Data were analyzed using SPSS (V19.0, IBM) and tested for normality using the Shapiro-Wilk test. Differences between means of groups were first tested using ANOVA and where appropriate using Tukey's post hoc test. In prior analysis, data found to be not normally distributed were analyzed using non-parametric methods. Group means such as CADASIL and controls were compared using analysis of variance (ANOVA) with post hoc Tukey tests for normal data or Kruskall-Wallis, Newman-Keuls and the Mann-Whitney U tests for non-normally distributed values, for example, differences between pathological variables and total GFAP positive cells or the percentage of clasmatodendrocytes in different groups. Spearman's rank ρ (rho) correlation was used to assess correlations between clinical and neuropsychometric variables or specific protein immunoreactivity measures and microvascular changes. Significant difference between means was considered when the P value was <0.05.
RESULTS
Astrocyte morphology revealed by GFAP immunohistochemistry
GFAP immunohistochemical staining of the WM of the anterior temporal pole from CADASIL subjects with WM hypersignals on MRI in life revealed abnormal astrocytes in the deeper WM (Figure 1) . Screening of immunostained sections from further afield in the WM of the PF, TL, PL and OL in CADASIL subjects indicated that GFAP antibodies essentially identified three types of morphologically distinct cells (Figure 2 ). There were the normal appearing star-like astrocytes with small bodies and long fibrous processes, which we designated as type A cells ( Figures 1I, 2A and 2B ). The other two had enlarged cell bodies with shortened or retracted fibers (type B) ( Figures  1F, 2C and 2D ) and rounded profiles without processes (type C) ( Figures 1C, 2E and 2F) . Many of the latter were found to be with smaller almost punctate cell bodies. The type B cells with enlarged cell bodies invariably exhibited thickened and shortened processes. The GFAP-positive cells types A to C collectively likely represented a continuous spectrum from normal to abnormal. The GFAPpositive cells were also immunostained by antibodies to ALDH1-L1 and DLL-1. The cytoplasmic immunoreactivities of these markers were similar to what we had observed in SVD cases from elders post-stroke survivors (6) . Similarly, several clasmatodendrocytes were immuostained by fibrinogen (data not shown).
Quantitative analyses (Figure 3 ) in all the 5 regions showed that the total population of GFAP-positive type C cells comprising counts from all regions was increased in CADASIL subjects compared to controls (P=0.037).
Type C cells appeared as clasmatodendrocytes, exhibiting an enlarged cell body and absence of processes. At higher magnification intracellular vacuoles could be discerned in these cells. There were no significant differences in type B cells (P=0.392) which appeared abnormal but these were not necessarily changed in CADASIL. However, boxplots also revealed a trend in less number of normal astrocytes in CADASIL subjects compared to similar age controls (P=0.051). We also noted higher percentage of type C cells (P=0.046) and a significantly lower percentage of type A cells (P=0.025) in CADASIL. When we compared percentage of the sum of all the abnormal cell (types B and C) there were significant differences (P=0.046) between CADASIL and controls. This suggested that the proportions of abnormal astrocytes were substantially increased in CADASIL. We found similar profiles of astrocytes with high variability in SVD cases but these were not quantified (6). However, it was unclear whether any of the astrocytes described here coincide with the most recently described cytotoxic astrocyte type A1 (21) or whether the WM astrocytes are a specialized type (5).
The regional distribution of each category of astrocytes across the five brain WM regions PF, anterior TP, TL, PL, and OL were qualitatively similar. However, there were considerable regional variations in clasmatodendritic numbers with the most robust change was in the temporal pole, consistent with WMHs upon MRI. There were Compare to controls, CADASIL subjects showed increased density of abnormal type C cells in all brain regions (A) (*P = 0.037) and increased percentage of abnormal type C cells in all brain regions (B) (*P = 0.046) and the anterior temporal pole (D) (*P = 0.011). When comparing each type of cell among CADASIL subjects, both density and percentage of abnormal type C cells were increased in all brain regions (A and B) and the anterior temporal pole (C and D) ( ‡ P < 0.01 throughout). However, differences between CADASIL and controls in the pre-frontal WM did not reach statistical significance (E and F). There was relatively low abundance of type B cells in the same screened regions. Other regions including the temporal, parietal and occipital WM similarly showed differences in percentage of abnormal to normal cells compared to controls (not shown).
consistently higher percentage of degenerated cells (type C) and lower percentage of type A (normal) cells in CADASIL compared to controls, as indicated by the median. The low percentage of type B cells with hyperplasic cell bodies and shortened processes in both disease and control groups across all brain areas were notable. Greater differences in the percentage of degenerating type C cells were apparent in the anterior temporal pole and temporal lobe with almost equivalent degree of changes in the prefrontal lobe (Figure 3) . Type A counts tended to be lower in the temporal pole (P=0.055) with a significant increase in the degenerating type C cells in the temporal lobe. We noted there was no clear relationship between specific genotype mutations and astrocyte pathology. This suggested NOTCH 3 mutations had no specific effects on degree of astrocyte change within the WM of brain regions examined.
Localization of AQP4 in astrocytes and microvascular markers
Double-immunofluorescence staining showed co-localization of AQP4 and GFAP in the end-feet of normal astrocytes (Figure 4) . Clasmatodendritic astrocytes showed localization of AQP4 and GFAP in the cell bodies. There was a clear indication that numerous clasmatodendritic astrocytes had retracted end-feet containing the water channel protein AQP4 in CADASIL and SVD cases (6) . As expected this was most prominent in the anterior temporal pole of CADASIL subjects.
Focusing on the frontal and anterior temporal pole WM, we first observed that the SI was increased in both CADASIL and SVD compared to their relative control age groups (P < 0.001 and P < 0.05, respectively). The mean SI value for frontal WM was 0.43 in CADASIL subjects versus 0.30 in similar age controls. Whereas, more relevant to the astrocytic pathology, in the anterior temporal pole the SI value was 0.46 in CADASIL compared to 0.31 in controls. In SVD, the SI value for the anterior temporal pole was 0.35 versus 0.31 in controls indicating on average 46% increment in CADASIL. The density of COL4 per area and ratio of GLUT1 to COL4 within microvessels were also increased indicating increased basement membranes in CADASIL and SVD but reduced endothelium. This was demonstrated by the decreased ICAM-1 immunoreactivity in the order CADASIL <SVD <young controls <old controls (P=0.001). CADASIL subjects showed 1.5-fold lower ICAM-1 immunoreactivity per area compared to young controls. Consistent with the data above on total GFAP reactive cells, we found ratios of GFAP to ICAM-1 immunoreactivity was increased in CADASIL and SVD cases compared to young and older controls (P=0.001)
Mechanisms of astrocytic cell deathMarkers of autophagy
In subsequent experiments, we explored mechanisms of astrocytic degeneration particularly focusing on the WM of the anterior temporal pole. We found that p62 immunoreactivities were localized in 90 ± 10% of the clamatodendritic astrocytes ( Figure 5 ). Immunostaining with other markers of the dysfunctional autophagy pathway suggested that LC3 was similarly highly co-localized in p62 immunoreactive cells. Thus, remarkably immunoreactivities of both LC3 and p62 were identified in clasmatodendritic astrocytes in CADASIL subjects but these were seldom evident in the similar age controls. Quantification of the co-labeled LC3 marker and GFAP-positive clasmatodendrocytes again showed 90 ± 9% co-localization compared to 0% in controls (P=0.000). We also noted Beclin-1 immunoreactivity in type C cells in the perivascular regions in SVD but not in controls (not shown). Furthermore, we reasoned that since astrocytes were essentially undergoing cell death that Caspase-3 or Apoptain might be activated. Caspase-3 is a critical for cell death, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins including the nuclear enzyme poly (ADP-ribose) polymerase. We found that the hypertrophic appearing astrocytes undergoing clasmatodendrosis were strikingly reactive for activated Caspase-3, whereas few if any Caspase-3-positive cells were observed in similar age controls ( Figure 6 ). In contrast, there were no apparent Caspase-3-positive cells in the neocortex in either CADASIL subjects or controls. Caspase-3 expression in CADASIL was specific to the WM in the damaged astrocytes and end-feet ( Figure 6 ).
DISCUSSION
We report severe albeit variable astrocytopathy in CADASIL. Examination of CADASIL brains revealed essentially three morphologically distinct GFAP-positive cell profiles. Higher percentage of abnormal and lower percentage of normal cells was indicative of greater clasmatodendrosis in CADASIL brains compared to controls. The abnormal type C largely comprised clasmatodendrocytes with retracted processes and dislocated end-feet containing AQP4, similar to what we recently reported in post-stroke survivors (6) . As increased astrocytopathy was evident, our findings implicate profound effects on disease pathophysiology, white matter lesions, vascular pathology, and BBB damage. Astrocytes are continually being broken down and new cells being formed but this may slow down with age and duration of disease (34) . Consistent with previous findings that large perivascular spaces were found in the WM of the temporal pole and greater pericyte and vascular smooth muscle cell degeneration (40), we suggest there is high turnover of astrocytes. This is likely increased also due to strategic location of subcortical infarcts (11) .
Our observations foremost provide evidence that astrocytic cell death may involve deregulation of autophagy. We found the co-localization of key markers in the autophagy pathway. In light of the current knowledge of the autophagy pathway, p62 likely binds to ubiquinated astrocytic proteins and these complexes are then recruited into LC3-labeled autophagosomes within dying cells. Accumulation of LC3-positive structures may suggest either autophagy upregulation at the level of autophagosome biogenesis or a block in autophagy at the later stages of the pathway, for example, impairment of autophagosomelysosome fusion (30) . However, simultaneous accumulation of LC3 and the autophagic substrate p62 strongly argues that the changes we observe are likely to be due to the autophagy blockade, which has been implicated in a range of neurological pathologies and could result in the loss of cell viability (22) . We propose that autophagy dysfunction or an insufficient autophagy in stress conditions may be the cause of apoptosis in CADASIL astrocytes and result in greater turnover of astrocytes. Mechanisms leading to autophagy dysfunction as well as those linking defective autophagy to death of astrocytes in CADASIL require further investigation.
Besides a consequence of the vascular pathology, is it plausible that astrocytes are directly affected by the mutant NOTCH3 receptor? Related to this proposal, Tang et al (35) recently showed that demyelination occurs secondary to vascular pathology. They showed that compared to cells overexpressing wild-type NOTCH3, oligodendrocytes overexpressing mutant NOTCH3 (R90C) were less viable and had a higher rate of apoptosis. Cells with mutant NOTCH3 also had higher levels of intrinsic mitochondrial apoptosis, extrinsic death receptor path-related apoptosis, and autophagy. Thus, early defects in glia influenced by NOTCH3 mutants may directly contribute to WM pathology in addition to secondary vascular defects. Consistent with our findings, in vitro model of ischemia induced by oxygen and glucose deprivation there was increased formation of autophagosomes and autolysosomes and monodansylcadaverine (MDC)-labeled vesicles in cultured astrocytes (25) . This was accompanied by increased production of microtubule-associated protein 1 light chain 3-II (LC3-II) and upregulation of Beclin 1, lysosomeassociated membrane protein 2 (LAMP2), and lysosomal cathepsin B expression in primary astrocytes.
Recent publications have described clasmatodendrosis in various neurodegenerative diseases and brain injury (32, 36) . However, it appears that the astrocytopathy largely associated with the WM in CADASIL is a profound, albeit related to the intensity of disease onset. Previous studies have suggested loss of AQP4 is associated with clasmatodendrosis and edema in neuromyelitis optica (23) . We recently reported AQP4 dislocation and and astrocytopathy/ clasmatodendrosis in post-stroke survivors and an experimental animal model (6) . Such similarities with CADASIL indicate that new information regarding treatment of neuromyelitis optica could also be applicable to CADASIL and SVD. The extent of astrocyte involvement in causing WM degeneration in acute haemorrhagic leukoencephalitis and Binswanger's disease has been hotly discussed. It is argued that clasmatodendrosis is causing demyelination in acute haemorrhagic leukoencephalitis because it occurs before any evidence of demyelination can be detected (29) whereas in Binswanger-like disease, clasmatodendrosis may occur without any signs of myelin loss (31) . The natural history of the changes in these and even neurodegenerative disorders suggests that arteriolosclerosis is one of the first changes (10) . The arteriopathy via reduction in the vascular bed could be the direct link in causing damage to astrocytes (33) . That this is plausible is because reducing brain perfusion even in subcortical structures and the WM with bilateral carotid artery stenosis non-invasively to the brain in mice leads to increased percentage of clasmatodendritic astrocytes (15, 16) . Damaged astrocytes would then escalate WM changes through progressively altered BBB function. BBB damage causes leaky vessels and fibrinogen, leaked from brain vessels to parenchyma, could be taken up by damaged astrocytes (clasmatodendrocytes), as several clasmatodendrocytes were immuostained by fibrinogen in CADASIL. At this stage, severity of clasmatodendrosis might be more severe and we observed them as Type C cells (severe clasmatodendrocytes). Furthermore, ischemic preconditioning prevents astrocyte injury through upregulating protective protein 14-3-3γ in murine models. Preservation of astrocytes could therefore offer a potential therapy in minimizing arteriopathy in CADASIL.
Our study is not without limitations. Despite analysis of a sizeable number of different CADASIL cases, we could not demonstrate the features of astrocytic cell death by ultrastructural morphology. The final proof how the process occurs could be resolved by this means but it was difficult to examine well preserve post-mortem tissue. Access to a larger cohort of CADASIL cases, there would be the possibility of exploring genotype-phenotype relationships and whether all genotypes have similar effects on astroglial demise. A recent study (13) showed that although specific NOTCH3 genotypes did not relate to WM changes, overrepresentation of the apolipoprotein E ε2 allele was associated with greater WM hyperintensity volumes. Our analysis was also limited to the examination of astrocytes in the WM. It is possible that dysfunctional gray matter astrocytes cause similar effects, particularly BBB disruption.
In summary, we report that there is significant astrocyte pathology in CADASIL, with the temporal lobe being most affected. We also provide clear evidence that astrocyte death in CADASIL involves the autophagy pathway. Our findings have implications for both CADASIL and aging related small vessel disease, where agents, which modulate astrocyte signaling, may provide therapeutic strategies to reduce the morbidity in vascular dementias.
